From The Hill
Novo Nordisk says its potential Wegovy successor helped patients lose more weight than Zepbound in a major clinical trial.
Novo Nordisk’s next-gen weight loss drug outperforms Zepbound in new trial
From The Hill
Novo Nordisk says its potential Wegovy successor helped patients lose more weight than Zepbound in a major clinical trial.